نتایج جستجو برای: fluvastatin lovastatin

تعداد نتایج: 2249  

Journal: :Chinese Medicine 2006
Jianping Liu Jing Zhang Yi Shi Sameline Grimsgaard Terje Alraek Vinjar Fønnebø

Extracts of Chinese red yeast rice (RYR, a traditional dietary seasoning of Monascus purpureus) contains several active ingredients including lovastatin, and several trials of its possible lipid-lowering effects have been conducted. This meta-analysis assesses the effectiveness and safety of RYR preparations on lipid modification in primary hyperlipidemia. We included randomized controlled tria...

Journal: :Hypertension 2000
U Ikeda M Shimpo R Ohki H Inaba M Takahashi K Yamamoto K Shimada

Matrix metalloproteinase-1 (MMP-1), also called interstitial collagenase, may play an important role in the pathogenesis of atherosclerosis and atherosclerotic plaque rupture. We investigated the effects of fluvastatin on MMP-1 expression in human vascular endothelial cells (ECs). The addition of fluvastatin decreased the basal MMP-1 levels in the culture media of ECs in a time-dependent (0 to ...

2003
SUKRUCAN H. BAYTAN AHMET AKGUN

BAYTAN, S.H., ALKANAT, M., OZEREN, M., EKINCI, M. and AKGUN, A. Fluvastatin Alters Psychomotor Performance and Daily Activity but not the Spatial Memory in Rats. Tohoku J. Exp. Med., 2006, 209 (4), 311-320 ── Statins, inhibitors of cholesterol synthesis for treating dyslipidemia and preventing cardiovascular complications, have been shown to alter central nervous system functions. Our aim was t...

Journal: :British journal of clinical pharmacology 1994
B Jacotot J D Banga P Pfister M Mehra

1. In this randomised, double-blind, placebo-controlled study, the efficacy of four dosages of fluvastatin (2.5, 5, 10 and 20 mg day-1) were assessed in 431 patients with primary hypercholesterolaemia recruited in 17 centres. 2. Following an 8-week dietary stabilisation phase and a 6-week placebo phase, the patients were randomised to receive placebo or fluvastatin 2.5, 5, 10 or 20 mg once dail...

2013
Ryszard Galus Krzysztof Włodarski Jacek Malejczyk Jarosław JóŸwiak

Our recent in vitro experiments suggest that fluvastatin may influence tyrosinase (key enzyme of melanogenesis) synthesis. The aim of the present study was to verify those findings in experiments, in vitro, in melanoma cell line, and in vivo, in mice. The expression of tyrosinase in B16F10 melanoma cell line, after induction of melanogenesis by UVB irradiation, was examined by Western blot anal...

2016
Yi-Chun Wang Tsung-Cheng Hsieh Chu-Lin Chou Jung-Lun Wu Te-Chao Fang Anastasios Lymperopoulos.

Some statins (simvastatin, lovastatin, and atorvastatin) are metabolized by cytochrome P450s 3A4 (CYP3A4). Inhibitors of CYP3A4 including some calcium channel blockers (CCBs) might increase statin blood concentration, owing to drug-drug interactions. Risk of adverse events such as acute kidney injury might occur following the coprescription of CYP3A4-metabolized statins and CCBs that inhibit CY...

Journal: :Pharmacological reports : PR 2014
Adrianna Sławińska-Brych Barbara Zdzisińska Martyna Kandefer-Szerszeń

BACKGROUND Fluvastatin is a member of the family of HMG-CoA reductase inhibitors (statins) extensively used in medical practice. Increasing evidence suggests that fluvastatin may be implicated in suppression of cancer growth and development. The aim of the present study was to investigate the anti-cancer potential of fluvastatin in C6 rat malignant glioma cells. METHODS First, the effects of ...

Journal: :The Journal of pharmacology and experimental therapeutics 2011
Kazuho Sakamoto Ikuo Wada Junko Kimura

HMG-CoA reductase inhibitor statins are used for the treatment of hypercholesterolemia. However, statins have adverse effects on skeletal muscles with unknown mechanism. We have reported previously that fluvastatin induced vacuolation and cell death in rat skeletal myofibers by depleting geranylgeranylpyrophosphate (GGPP) and suppressing small GTPases, particularly Rab (FASEB J 21:4087-4094, 20...

Journal: :Heart 2004
C H Lee P de Feyter P W Serruys F Saia P A Lemos D Goedhart P R Soares V A W M Umans M Ciccone M Cortellaro

AIMS To investigate the effect on risk of major adverse cardiac events (MACE) of lipid lowering treatment with fluvastatin 80 mg/day after a first percutaneous coronary intervention in patients with stable and unstable angina. METHOD AND RESULTS This prespecified subgroup analysis of the LIPS (Lescol intervention prevention study) analysed 1658 patients with documented diagnosis; 824 had unst...

Journal: :Arteriosclerosis, thrombosis, and vascular biology 2005
Kenichi Sakamoto Takahisa Murata Hiroko Chuma Masatoshi Hori Hiroshi Ozaki

OBJECTIVE We examined the inhibitory mechanisms of fluvastatin on FBS-induced vascular hypertrophy assessed by organ-cultured rat tail artery. METHODS AND RESULTS After 5 days of culture with 10% FBS, hyperplastic morphological changes in the media layer were induced. Treatment with 1 mumol/L fluvastatin significantly inhibited these changes. In the FBS-cultured arteries, the protein expressi...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید